Skip to main content

Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026

Houston, Texas and Tuebingen, Germany, July 17, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today announced three presentations at the European Society for Medical Oncology (ESMO) Congress 2026, to be held from October 23-27, 2026, in Madrid, Spain. The three presentations will include:Phase 1b data from anzu-cel, the Company’s lead PRAME cell therapy, in metastatic cutaneous and uveal melanoma, focusing on predictors of durable response Phase 1 data from IMA203CD8 PRAME cell therapy across multiple PRAME-positive solid tumors, including durability follow-up at clinically relevant dose levels in gynecologic cancers, supporting the broad applicability of IMA203CD8 across diverse tumor...

Continue reading

AB Novaturas notification on the allocation of new shares to Mr Neşet Koçkar and on the final number of the allocated new shares

On 17 July 2026, the Board of AB Novaturas (hereinafter – the Company), referring to the resolutions of the (repeated) annual general meeting of shareholders of the Company held on 12 June 2026 (hereinafter – the Resolutions), also the resolution of the Board of the Company adopted on 15 July 2026 on the allocation of new shares to the Existing Shareholders of the Company (as described in the exemption document of the Company, dated 30 June 2026), inter alia decided: (i) to allocate 10,010,362 new shares to Mr Neşet Koçkar (from this number 3,436,477 shares were allocated to Mr. Neşet Koçkar upon his exercise of his pre-emptive right, and 6,573,885 shares were allocated upon the subscription of shares not subscribed for by other shareholders of the Company); (ii) to determine that the final number of new shares of the Company...

Continue reading

Huadi International Group Co., Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Wenzhou, China, July 17, 2026 (GLOBE NEWSWIRE) — Huadi International Group Co., Ltd. (“HUDI” or the “Company”) (NASDAQ: HUDI), a developer and manufacturer of industrial stainless steel seamless pipes and tubes products in China, confirmed that on July 14, 2026, it received a Nasdaq Listing Qualifications Staff Determination Letter (the “Notice”) stating that the Company is not in compliance with Nasdaq’s minimum bid price requirement. The Notice advised that for a period of 30 consecutive business days, the closing bid price per share for the Company’s ordinary shares was below the $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5550(a)(2). This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification. The Notice does not...

Continue reading

Gemini to Announce Second Quarter 2026 Results on August 13, 2026

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) — Gemini Space Station, Inc. (“Gemini”) (NASDAQ: GEMI), a global crypto and prediction markets platform, today announced it will release its second quarter 2026 financial results after market close on Thursday, August 13, 2026. Management will host a conference call on Friday, August 14, 2026 at 8:30 a.m. ET to discuss the results. Call registration and webcast details will be posted to the Events page of Gemini’s Investor Relations website (https://investors.gemini.com/) ahead of the call. Gemini also plans to host the webcast on its X and YouTube channels. Following the call, a replay and transcript will be available on Gemini’s Investor Relations website. Channels for Disclosure of InformationAs a reminder, Gemini announces material information to the public through filings with the Securities...

Continue reading

Salem Media Announces Retirement of Salem Surround Executive Jon Latzer

CAMARILLO, Calif., July 17, 2026 (GLOBE NEWSWIRE) — Salem Media, Inc. (OTCQX: SALM) announced a leadership transition for Salem Surround, the company’s digital marketing agency, as longtime Salem executive Jon Latzer prepares to retire following his many years of service to the company.Latzer has been instrumental in the growth of Salem Surround, helping expand the company’s digital marketing capabilities while supporting local markets, sales teams, clients, and vendor partnerships across the country. His leadership has helped position Salem Surround as a key part of Salem’s broader digital strategy. “Jon has been a tremendous leader and trusted partner throughout his time at Salem,” said Jamie Cohen, Chief Digital Officer of Salem Media. “He has helped shape Salem Surround into the business it is today through...

Continue reading

Arch Biopartners Engages Private Laboratory to Accelerate IL-32 Chronic Kidney Disease Program

TORONTO, July 17, 2026 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (TSX Venture: ARCH and OTCQB: ACHFF) today announced that it has engaged a U.S.-based laboratory specializing in bioengineering to accelerate the Company’s pre-IND IL-32 chronic kidney disease (“CKD”) program. The U.S.-based lab was selected for its core competencies in the areas required to support the IL-32 program. It will perform studies on behalf of Arch to generate proprietary data and support the Company’s patent portfolio covering its IL-32 drug candidates and related method-of-use claims. These studies represent the next stage of drug development following the identification of IL-32 as a potential therapeutic target in diabetic kidney disease. “This research contract is an important step in advancing the Company’s IL-32 CKD drug development program,” said...

Continue reading

Auction result of Treasury Bonds – RIKB 38 0215 – RIKS 29 0917

Series  RIKB 38 0215 RIKS 29 0917Settlement Date  07/22/2026 07/22/2026Total Amount Allocated (MM)  4,510 1,350All Bids Awarded At (Price / Yield)  96.725 / 6.910 99.725 / 3.591Total Number of Bids Received  23 5Total Amount of All Bids Received (MM)  5,310 1,350Total Number of Successful Bids  19 5Number of Bids Allocated in Full  19 5Lowest Price / Highest Yield Allocated  96.725 / 6.910 99.725 / 3.591Highest Price / Lowest Yield Allocated  97.000 / 6.880 99.810 / 3.562Lowest Price / Highest Yield Allocated in Full  96.725 / 6.910 99.725 / 3.591Weighted Average of Successful Bids (Price/Yield)  96.803 / 6.900 99.738 / 3.586Best Bid (Price / Yield)  97.000 / 6.880 99.810 / 3.562Worst Bid (Price / Yield)  96.420 / 6.950 99.725 / 3.591Weighted Average of All Bids Received (Price / Yield)  96.776 / 6.910 99.738 / 3.586Percentage...

Continue reading

Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) — Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating autoimmune diseases, today announced that the Compensation Committee of its Board of Directors approved new employee inducement grants covering an aggregate of 288,800 restricted stock units (the “Inducement Grants”) for 17 new employees. The Inducement Grants were granted pursuant to Artiva’s 2025 Inducement Plan (the “Inducement Plan”), and were effective July 14, 2026. The Inducement Grants will vest over four years, with vesting aligned to quarterly vesting dates of February 15, May 15, August 15 and November 15 (the “Quarterly Vesting Dates”). For each new employee, 25% of the Inducement Grant will...

Continue reading

Camping World Holdings, Inc. to Announce Second Quarter 2026 Earnings on July 29, 2026, with a Call Premarket on July 30, 2026

LINCOLNSHIRE, Ill., July 17, 2026 (GLOBE NEWSWIRE) — Camping World Holdings, Inc. (NYSE: CWH) (the “Company”) today announced that its financial results for the second quarter 2026 will be released after the market closes on Wednesday, July 29, 2026. The Company will host a conference call on Thursday, July 30, 2026 at 7:30 a.m. Central Time to discuss the financial results. Investors and analysts interested in participating in the call are invited to dial 800-717-1738 (international callers please dial 1-646-307-1865) approximately 10 minutes prior to the start of the call. A live audio webcast of the conference call will be available online at http://investor.campingworld.com. A taped replay of the conference call will be available within two hours of the conclusion of the call and can be accessed both online and by...

Continue reading

Wakefern and ShopRite Expand Edible Garden’s Successful “Garden Starters” Program with Midsummer Promotion

Strong Consumer Response Drives Expanded Seasonal Merchandising Initiative Across Participating ShopRite Locations BELVIDERE, N.J., July 17, 2026 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce, and developer of the Zero-Waste Inspired® mission and Farm-to-Formula® platform, today announced that Wakefern Food Corp. is expanding the Company’s Garden Starters pallet display program with a new midsummer promotional event across participating ShopRite locations. Building on strong customer response during the spring season, the expanded promotion is designed to meet continued consumer demand for fresh, living herbs while encouraging home gardening and outdoor entertaining throughout...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.